EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist



Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist



Urology 57(6 Suppl 1): 118-118




(PDF same-day service: $19.90)

Accession: 035980512

Download citation: RISBibTeXText

PMID: 11378098

DOI: 10.1016/s0090-4295(01)01066-4



Related references

The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis. Journal of Urology 166(5): 1734-1737, November, 2001

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Archives of Internal Medicine 158(11): 1213-1220, 1998

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Archives of Internal Medicine 160(16): 2481-2488, 2000

Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast. Acta Dermato-Venereologica 80(3): 229-229, 2000

Treatment of chronic cough in children with montelukast,a leukotriene receptor antagonist. Journal of Asthma 41(7): 715-720, 2004

Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(8): 659-667, 2015

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. New England Journal of Medicine 339(3): 147-152, 1998

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108(3): E48-E48, 2001

Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast. Acta Dermatovenerologica Alpina, Pannonica, et Adriatica 14(3): 115-119, 2005

Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis. Dermatologic Therapy 23(1): 90-93, 2010

Effect of treatment of montelukast, a once-daily leukotriene receptor antagonist, in the treatment of mild to moderate asthma due to dermatophagoides pteronyssinus. Immunology 98(suppl 1): 73, 1999

Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?. Aids 21(3): 383-384, 2007

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. European Respiratory Journal 11(6): 1232-1239, 1998

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. Journal of Allergy and Clinical Immunology 102(1): 50-56, 1998